EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies

Jenny Parkkinen, Ratul Bhowmik, Martti Tolvanen, Fabrizio Carta, Claudiu T Supuran, Seppo Parkkila, Ashok Aspatwar

The Enzymes · 2024

DOI: 10.1016/bs.enz.2024.05.012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Enzymes, 2024. Verfasst von Jenny Parkkinen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Carbonic Anhydrases, Antitubercular Agents, Carbonic Anhydrase Inhibitors. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 121 Literaturangaben. Gefördert von: Tampereen Tuberkuloosisäätiö, Jane ja Aatos Erkon Säätiö, Research Council of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis (Mtb), which causes tuberculosis (TB), is still a major global health problem. According to the World Health Organization (WHO), TB still causes more deaths worldwide than any other infectious agent. Drug-sensitive TB is treatable using first-line drugs; treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB requires second- and third-line drugs. However, due to the long duration of treatment, the noncompliance of patients with different levels of resistance of Mtb to these drugs has worsened the situation. Previously developed anti-TB drugs targeted the replication machinery, protein synthesis, and cell wall biosynthesis pathways of Mtb. Therefore, novel drugs targeting alternate pathways crucial for the survival and pathogenesis of Mtb in the human host are needed. The genome of Mtb encodes three β-carbonic anhydrases (CAs) that are fundamental for pH homeostasis, hypoxia, survival, and pathogenesis. Recently, several studies have shown that the β-CAs of Mtb could be inhibited both in vitro and in vivo using small chemical molecules, suggesting that these enzymes could be novel targets for developing anti-TB compounds that are devoid of resistance by Mtb. In addition, homologs of β-CAs are absent in humans; therefore, drugs developed to target these enzymes might have minimal off-target effects. In this work, we describe the roles of β-CAs in Mtb and discuss bioinformatics and cheminformatics tools used in development and discovery of novel inhibitors of these enzymes. In addition, we summarize the in vitro and in vivo studies demonstrating that the β-CAs of Mtb are indeed druggable targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisCarbonic AnhydrasesAntitubercular AgentsCarbonic Anhydrase InhibitorsTuberculosisHumansAnimalsBacterial Proteins

Stichwörter der Autor:innen

Drug developmentInhibitorsMycobacterium tuberculosisTuberculosisβ-Carbonic anhydrases

Substanzen

Carbonic AnhydrasesAntitubercular AgentsCarbonic Anhydrase InhibitorsBacterial Proteins

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Department of Computing, University of Turku, Finland.
  • Neurofarba Department, Sezione di Chimica Farmaceutica e Nutraceutica, Università degli Studi di Firenze, Firenze, Italy.
  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Fimlab Ltd. and Tampere University Hospital, Tampere, Finland.
  • Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. Electronic address: ashok.aspatwar@tuni.fi.

Förderung

  • Tampereen Tuberkuloosisäätiö
  • Jane ja Aatos Erkon Säätiö
  • Research Council of Finland
  • Finnish Film Foundation

Zitieren

APA

Parkkinen, J., Bhowmik, R., Tolvanen, M., Carta, F., Supuran, C. T., Parkkila, S., & Aspatwar, A. (2024). Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies. The Enzymes. https://doi.org/10.1016/bs.enz.2024.05.012

Vancouver

Parkkinen J, Bhowmik R, Tolvanen M, Carta F, Supuran CT, Parkkila S, et al. Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies. The Enzymes. 2024. doi:10.1016/bs.enz.2024.05.012

BibTeX
@article{Parkkinen2024,
  author = {Parkkinen, Jenny and Bhowmik, Ratul and Tolvanen, Martti and Carta, Fabrizio and Supuran, Claudiu T and Parkkila, Seppo and Aspatwar, Ashok},
  title = {Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies},
  journal = {The Enzymes},
  year = {2024},
  doi = {10.1016/bs.enz.2024.05.012}
}
Kostenlos starten →